Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management.
Piyong SolaPraveen Thaggikuppe KrishnamurthyPavan Kumar ChintamaneniSai Kiran S S PindiproluMamta KumariPublished in: Expert opinion on drug delivery (2020)
Brain targeted delivery of β2AR agonists via various nano delivery systems will significantly downregulate SNCA gene expression in PD and also overcomes peripheral side effects of β2AR agonists.